SCHEMBL6423796

SCHEMBL6423796

Cc1c([C@H](CC2CCCC2)C(=O)O)c2c(F)c(O)c(F)cc2n1C(=O)c1cccc(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.36
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 2/20 0.36
SLC6A9 P48067 1/20 0.34
SLC6A5 Q9Y345 1/20 0.34
GPR142 Q7Z601 1/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
HSD11B1 P28845 1/20 0.34
POLB P06746 1/20 0.34
CASP3 P42574 1/20 0.34
LMNA P02545 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
GRN P28799 1/20 0.33
SORT1 Q99523 1/20 0.33
PTGER1 P34995 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424757 0.98 GPR142 (0.36) METAP2ALDH1A1L3MBTL1KDM4ESLC6A9
SCHEMBL6424977 0.92 TDP1 (0.36) ALDH1A1KDM4EMEN1KMT2AHSD11B1
SCHEMBL6425046 0.91 USP2 (0.35) ALDH1A1KDM4EMEN1KMT2AHSD11B1
SCHEMBL6424288 0.91 AKR1C3 (0.39) KDM4EMEN1KMT2ALMNA
SCHEMBL6425954 0.91 USP30 (0.33) MEN1KMT2AHSD11B1LMNAGRN
SCHEMBL6426870 0.90 METAP2 (0.36) METAP2ALDH1A1L3MBTL1KDM4ESLC6A9
SCHEMBL6453537 0.89 PDE2A (0.33) GRNSORT1
SCHEMBL6424159 0.89 TSHR (0.34) ALDH1A1HSD11B1
SCHEMBL6423595 0.89 MEN1 (0.32) MEN1KMT2AHSD11B1LMNA
SCHEMBL6425574 0.89 AKR1C3 (0.39) KDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 METAP2 693/4885ALDH1A1 630/4885L3MBTL1 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.